AG
AZN icon

Advisor Group’s AstraZeneca AZN Stock Holding History

Advisor Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.95M Sell
19,504
-2,414
-11% -$227K 0.01% 828
2019
Q3 		$1.96M Sell
21,918
-49
-0.2% -$4.25K 0.01% 774
2019
Q2 		$1.81M Sell
21,967
-344
-2% -$27K 0.01% 797
2019
Q1 		$1.8M Sell
22,311
-11,488
-34% -$905K 0.01% 763
2018
Q4 		$2.57M Buy
33,799
+2,417
+8% +$189K 0.03% 536
2018
Q3 		$2.48M Buy
31,382
+2,285
+8% +$173K 0.03% 569
2018
Q2 		$2.04M Sell
29,097
-5,207
-15% -$375K 0.03% 542
2018
Q1 		$2.4M Sell
34,304
-4,348
-11% -$301K 0.03% 490
2017
Q4 		$2.68M Buy
38,652
+1,091
+3% +$73.6K 0.04% 456
2017
Q3 		$2.55M Buy
37,561
+5,991
+19% +$378K 0.04% 422
2017
Q2 		$2.15M Buy
31,570
+700
+2% +$45.7K 0.04% 459
2017
Q1 		$1.92M Buy
30,870
+4,781
+18% +$278K 0.04% 476
2016
Q4 		$1.43M Sell
26,089
-3,498
-12% -$199K 0.03% 523
2016
Q3 		$1.94M Buy
29,587
+3,607
+14% +$236K 0.05% 413
2016
Q2 		$1.57M Buy
+25,980
New +$1.51M 0.04% 453

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Advisor Group's AZN Position: Q4 2019 in Review

Advisor Group reduced its AstraZeneca (AZN) stake by 11% in Q4 2019, selling an estimated $227K and leaving 19,504 shares worth $1.95M. The position accounts for 0.01% of the portfolio, ranked #828.

Advisor Group first reported a position in AZN in Q2 2016 and has held it in 15 quarters since. The position peaked at $2.68M in Q4 2017. 633 funds tracked by Wall St. Rank hold AZN as of Q4 2019.

  • Advisor Group held 19,504 shares of AstraZeneca worth $1.95M as of Q4 2019.
  • Advisor Group sold 2,414 AstraZeneca shares in Q4 2019, an estimated $227K.
  • AstraZeneca made up 0.01% of Advisor Group's portfolio in Q4 2019, its #828 holding.
  • Advisor Group first reported a position in AstraZeneca in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's AstraZeneca position peaked at $2.68M in Q4 2017.
  • 633 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.